TABLE II.
GENES | OBESITY | CRC | OSTEOPOROSIS |
---|---|---|---|
PPP1R15A* | In the bone morphogenetic protein (BMP) signaling pathway, which regulates appetite [34] | Mutations in the BMP pathway are related with colorectal carcinogenesis [35] | In the bone morphogenetic protein signaling pathway, which are associated with bone-related diseases, such as osteoporosis [36] |
FOS | diet-induced obesity is accompanied by alteration of FOS expression [37] | Proto-oncogene, in the KEGG pathway of colorectal cancer [38] | Mice lacking c-fos develop severe osteopetrosis [39] |
FOSB | positive association between maternal obesity [40] | Oncogene, regulators of cell proliferation, has a debatable impact on CRC patient survival [41] | Overexpression of FosB increases bone formation [42] |
HADHA* | Associated with multiple fatty acid metabolism pathways [43] | Unknown. Associated with breast cancer [44] | Unknown. |
JUN | The c-Jun NH2-terminal Kinase Promotes Insulin Resistance [45] | Proto-oncogene, in the KEGG pathway of colorectal cancer [38] | Associated with osteogenesis [46, 47] |
NRIP1* | Down-regulated in obese subjects, may suggest a compensatory mechanism to favor energy expenditure and reduce fat accumulation in obesity states [48] | Unknown. Involved in regulation of E2F1, an oncogene [49] | Modulates transcriptional activity of the estrogen receptor. Interact with ESR1 and ESR2 in osteoporosis [50] |
novel genes not involving insulin resistance pathways